New Study on the Prevention of Postpartum Depression: Intervention With SNOOⓇ May Reduce PPD Rates By 20-50%
Retrieved on:
Tuesday, May 24, 2022
Insomnia, Risk, History, Mother, Hospital, Cooking, Incidence, Multimedia, Woman, University, PPD, Parent, Hortensia Fussy, Depressive, Associate, Infant, COVID-19, Sleep deprivation, Depression, University of Colorado Colorado Springs, Harvey Karp, Sleep, Partnership, Child, Anxiety, UCCS, Comparative effectiveness research, Mental health, Brigham and Women's Hospital, COVID, LOS, NICU, Uranium, Birth control, Pharmaceutical industry, Medicine, Toy, Research, Block
LOS ANGELES, May 24, 2022 /PRNewswire/ -- Researchers at The University of Colorado partnered with Happiest Baby, makers of SNOO, to study the link between sleep and rates of postpartum depression (PPD). Findings suggest that the smart bassinet's ability to soothe infant crying and fussiness holds substantial potential to support new parents and significantly reduce rates of postpartum depression.
Key Points:
- Findings suggest that the smart bassinet's ability to soothe infant crying and fussiness holds substantial potential to support new parents and significantly reduce rates of postpartum depression.
- While 18.2% using SNOO met the clinical criteria for insomnia, this was lower than the expected incidence of approximately 46% .
- Yet, in this study, mothers with prior depressionwho used SNOO had less PPD than those at low risk.
- SNOO is not cleared or approved for the prevention or treatment of anxiety, insomnia, depression, or postpartum depression (PPD).